The weekly technical trend for Amrutanjan Health Care has transitioned to sideways from a previously mildly bullish outlook. Examining key technical indicators, the Moving Average Convergence Divergence (MACD) shows a mildly bearish signal on the weekly chart, while the monthly MACD remains bullish. The Relative Strength Index (RSI) does not currently signal any definitive momentum on either weekly or monthly timeframes, suggesting a neutral stance in terms of overbought or oversold conditions.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- New profitability achieved
- Growth momentum building
- Under-the-radar entry
Bollinger Bands analysis reveals bearish signals on both weekly and monthly charts, indicating increased volatility and potential pressure on price levels. Daily moving averages, however, maintain a mildly bullish stance, suggesting some short-term upward momentum. The Know Sure Thing (KST) indicator reflects mildly bearish conditions on both weekly and monthly scales, reinforcing the mixed signals from other momentum indicators.
Additional technical frameworks such as Dow Theory and On-Balance Volume (OBV) do not currently indicate any clear trend on weekly or monthly charts, highlighting a lack of directional conviction in the stock’s price movement. This absence of trend confirmation aligns with the sideways technical trend classification, signalling a period of consolidation or indecision among market participants.
From a broader market perspective, Amrutanjan Health Care’s returns have shown varied performance relative to the Sensex benchmark. Over the past week and month, the stock has recorded negative returns of -1.91% and -1.54% respectively, while the Sensex posted positive returns of 0.96% and 0.86% over the same periods. Year-to-date, the stock’s return stands at -2.47%, contrasting with the Sensex’s 8.36% gain. Over longer horizons, the stock’s 1-year return is 0.66%, compared to Sensex’s 9.48%, and the 3-year return is -1.10% versus Sensex’s 37.31%. The 5-year and 10-year returns for Amrutanjan Health Care are 42.16% and 188.63%, respectively, trailing the Sensex’s 91.65% and 232.28% over the same durations.
Amrutanjan Health Care or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- SwitchER analysis complete
- Superior alternatives found
- Multi-parameter evaluation
Price volatility today ranged between ₹706.10 and ₹710.00, with the stock trading below its 52-week high of ₹829.00 but comfortably above the 52-week low of ₹548.05. The market capitalisation grade remains modest, reflecting the company’s mid-tier valuation within the Pharmaceuticals & Biotechnology sector. The recent adjustment in the Mojo Score to 61.0 and a change in grade from Buy to Hold on 18 Nov 2025 indicate a revision in the evaluation of the stock’s technical parameters, particularly triggered by the technical_dot signal on 19 Nov 2025.
Investors analysing Amrutanjan Health Care should consider the current technical momentum shift and the mixed signals from key indicators such as MACD, RSI, Bollinger Bands, and moving averages. The sideways trend suggests a phase of consolidation, where price movements may lack clear direction until further catalyst or market developments emerge. Comparing the stock’s returns with the Sensex benchmark highlights a relative underperformance in recent periods, which may influence portfolio allocation decisions within the Pharmaceuticals & Biotechnology sector.
Overall, the technical parameter changes for Amrutanjan Health Care reflect a nuanced market stance, with short-term indicators showing mild bullishness offset by bearish signals on longer-term charts. This complex technical landscape calls for careful monitoring of momentum shifts and volume trends to better understand potential future price trajectories.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
